IGF1 and cancer: It is noteworthy that NRF2 silencing strongly altered the mitochondrial morphology, biogenesis and turnover, indicating that NRF2 is a key effector of the IGF-1 pathway connecting cell growth to mitochondrial homeostasis and cell survival in cancer [68].